REPORT ID 6916

United States Central Nervous System Biomarkers Market Report 2017

Publish Date
1-Nov-17
Pages
101
Format
Electronic (PDF)

In this report, the United States Central Nervous System Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Central Nervous System Biomarkers in these regions, from 2012 to 2022 (forecast).

United States Central Nervous System Biomarkers market competition by top manufacturers/players, with Central Nervous System Biomarkers sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Thermo Fisher Scientific
    Merck & Co
    AbaStar MDx Inc
    Abiant, Inc
    Avacta Group Plc
    Diagenic Asa
    Banyan Biomarkers
    Avid Radiopharmaceuticals Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Safety Biomarker
    Efficacy Biomarker
    Validation Biomarker
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Central Nervous System Biomarkers Market Report 2017
1 Central Nervous System Biomarkers Overview
    1.1 Product Overview and Scope of Central Nervous System Biomarkers
    1.2 Classification of Central Nervous System Biomarkers by Product Category
        1.2.1 United States Central Nervous System Biomarkers Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Central Nervous System Biomarkers Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Safety Biomarker
        1.2.4 Efficacy Biomarker
        1.2.5 Validation Biomarker
        1.2.6 Other
    1.3 United States Central Nervous System Biomarkers Market by Application/End Users
        1.3.1 United States Central Nervous System Biomarkers Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 United States Central Nervous System Biomarkers Market by Region
        1.4.1 United States Central Nervous System Biomarkers Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Central Nervous System Biomarkers Status and Prospect (2012-2022)
        1.4.3 Southwest Central Nervous System Biomarkers Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Central Nervous System Biomarkers Status and Prospect (2012-2022)
        1.4.5 New England Central Nervous System Biomarkers Status and Prospect (2012-2022)
        1.4.6 The South Central Nervous System Biomarkers Status and Prospect (2012-2022)
        1.4.7 The Midwest Central Nervous System Biomarkers Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Central Nervous System Biomarkers (2012-2022)
        1.5.1 United States Central Nervous System Biomarkers Sales and Growth Rate (2012-2022)
        1.5.2 United States Central Nervous System Biomarkers Revenue and Growth Rate (2012-2022)

2 United States Central Nervous System Biomarkers Market Competition by Players/Suppliers
    2.1 United States Central Nervous System Biomarkers Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Central Nervous System Biomarkers Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Central Nervous System Biomarkers Average Price by Players/Suppliers (2012-2017)
    2.4 United States Central Nervous System Biomarkers Market Competitive Situation and Trends
        2.4.1 United States Central Nervous System Biomarkers Market Concentration Rate
        2.4.2 United States Central Nervous System Biomarkers Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Central Nervous System Biomarkers Manufacturing Base Distribution, Sales Area, Product Type

3 United States Central Nervous System Biomarkers Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Central Nervous System Biomarkers Sales and Market Share by Region (2012-2017)
    3.2 United States Central Nervous System Biomarkers Revenue and Market Share by Region (2012-2017)
    3.3 United States Central Nervous System Biomarkers Price by Region (2012-2017)

4 United States Central Nervous System Biomarkers Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Central Nervous System Biomarkers Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Central Nervous System Biomarkers Revenue and Market Share by Type (2012-2017)
    4.3 United States Central Nervous System Biomarkers Price by Type (2012-2017)
    4.4 United States Central Nervous System Biomarkers Sales Growth Rate by Type (2012-2017)

5 United States Central Nervous System Biomarkers Sales (Volume) by Application (2012-2017)
    5.1 United States Central Nervous System Biomarkers Sales and Market Share by Application (2012-2017)
    5.2 United States Central Nervous System Biomarkers Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Central Nervous System Biomarkers Players/Suppliers Profiles and Sales Data
    6.1 Thermo Fisher Scientific
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Central Nervous System Biomarkers Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Thermo Fisher Scientific Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Merck & Co
        6.2.2 Central Nervous System Biomarkers Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck & Co Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 AbaStar MDx Inc
        6.3.2 Central Nervous System Biomarkers Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 AbaStar MDx Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Abiant, Inc
        6.4.2 Central Nervous System Biomarkers Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Abiant, Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Avacta Group Plc
        6.5.2 Central Nervous System Biomarkers Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Avacta Group Plc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Diagenic Asa
        6.6.2 Central Nervous System Biomarkers Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Diagenic Asa Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Banyan Biomarkers
        6.7.2 Central Nervous System Biomarkers Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Banyan Biomarkers Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Avid Radiopharmaceuticals Inc
        6.8.2 Central Nervous System Biomarkers Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Central Nervous System Biomarkers Manufacturing Cost Analysis
    7.1 Central Nervous System Biomarkers Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Central Nervous System Biomarkers

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Central Nervous System Biomarkers Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Central Nervous System Biomarkers Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Central Nervous System Biomarkers Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Central Nervous System Biomarkers Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Central Nervous System Biomarkers Sales Volume Forecast by Type (2017-2022)
    11.3 United States Central Nervous System Biomarkers Sales Volume Forecast by Application (2017-2022)
    11.4 United States Central Nervous System Biomarkers Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer